Structural Basis of Synercid® (Quinupristin-Dalfopristin) Resistance in Gram-positive Bacterial Pathogens
Open accessThe DOI matches its Crossref record.
Abstract
Synercid, a new semisynthetic streptogramin-derived antibiotic containing dalfopristin and quinupristin, is used in treatment of life-threatening infections caused by glycopeptide-resistant Enterococcus faecium and other bacterial pathogens. However, dissemination of genes encoding virginiamycin acetyltransferases, enzymes that confer resistance to streptogramins, threatens to limit the medical utility of the quinupristin-dalfopristin combination. Here we present structures of virginiamycin acetyltransferase D (VatD) determined at 1.8 A resolution in the absence of ligands, at 2.8 A resolution bound to dalfopristin, and at 3.0 A resolution in the presence of acetyl-coenzyme A. Dalfopristin is bound by VatD in a similar conformation to that described previously for the streptogramin virginiamycin M1. However, specific interactions with the substrate are altered as a consequence of a conformational change in the pyrollidine ring that is propagated to adjacent constituents of the dalfopristin macrocycle. Inactivation of dalfopristin involves acetyl transfer from acetyl-coenzyme A to the sole (O-18) hydroxy group of the antibiotic that lies close to the side chain of the strictly conserved residue, His-82. Replacement of residue 82 by alanine is accompanied by a fall in specific activity of >105-fold, indicating that the imidazole moiety of His-82 is a major determinant of catalytic rate enhancement by VatD. The structure of the VatD-dalfopristin complex can be used to predict positions where further structural modification of the drug might preclude enzyme binding and thereby circumvent Synercid resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
“faecium , including drug modification, inactivation and efflux through virginiamycin acetyltransferase (Vat)(virginiamycin is another streptogramin mixture that is similar to quinupristin–dalfopristin), virginiamycin B lyase (Vgb) and the ATP-binding cassette protein macrolide–streptogramin resistance protein (MsrC),…”
BackgroundBacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
“One of these, VatD, has been crystallized and its three-dimensional structure solved [40,41].”
BackgroundStreptogramins, Oxazolidinones, and Other Inhibitors of Bacterial Protein Synthesis
Mukhtar, T. A., & Wright, G. D. (2005) · Chemical Reviews · doi:10.1021/cr030110z · Cited by 371
Mechanisms of action of newer antibiotics for Gram-positive pathogens
Hancock, R. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70051-7 · Cited by 295
β‐Rolls, β‐Helices, and Other β‐Solenoid Proteins
Kajava, A. V., & Steven, A. C. (2006) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(06)73003-0 · Cited by 149
Metadata
- Authors
- Kehoe, L. E., Snidwongse, J., Courvalin, P., Rafferty, J. B., & Murray, I. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 278
- Issue
- 32
- Pages
- 29963-29970
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2006178873
- Cited by
- 40
- References
- 0
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural Basis of Synercid® (Quinupristin-Dalfopristin) Resistance in Gram-positive Bacterial Pathogens. https://app.cochat.ai/papers/10.1074/jbc.m303766200
- The paper
- Kehoe, L. E., Snidwongse, J., Courvalin, P., Rafferty, J. B., & Murray, I. A. (2003). Structural Basis of Synercid® (Quinupristin-Dalfopristin) Resistance in Gram-positive Bacterial Pathogens. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m303766200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.